Inserm Transfert and MassBio announce a partnership to foster innovation, technology transfer and entrepreneurship between France and Massachusetts (USA).
QIAGEN Marseille acquires exclusive rights from Inserm Transfert SA and Inserm on HSP110 mutations for colorectal cancer.
By Plimun Web Design
|
INSERM TRANSFERT
Paris Biopark - 7 rue Watt - 75013 PARIS
|